LifeTech Capital Downgrades Marina Biotech To Neutral, $0.30 PT - Moderna (NASDAQ:MRNA)

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

LifeTech Capital downgraded its Marina Biotech (NASDAQ: MRNA) rating from Strong Speculative Buy to Neutral and lowered its Marina Biotech price target from $2.50 to $0.30 in a research report published today. LifeTech Capital In the report, LifeTech Capital states, "Although Marina's announced financing is expected to yield much needed cash to the company (closing on or about May 20th), the terms result in significant dilution that adversely impacts projected earnings per share in our financial model beyond our projected dilution for future capital requirements."Shares of Marina Biotech were trading at $0.24 at the time of posting, down 3.08% from Tuesday's market close.

Crypto Whales Are Loading Up — Are You?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!